Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioScreen Testing Services Contribute to NDA Approval | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

BioScreen Testing Services Contribute to NDA Approval

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Spectrum Pharmaceuticals, Inc. received approval to market Levoleucovorin for Injection from the FDA following application submissions supported by data from BioScreen Testing Services, Inc.  
    
“We offer our sincere congratulations to Spectrum,” said Bradford Rope, president of BioScreen Testing Services. “BioScreen looks forward to a continuing partnership, providing release testing support during the manufacture of Levoleucovorin, as well as additional development support for the many drugs in Spectrum’s pipeline. BioScreen provides contract testing services to companies and has contributed data to support many submissions to the FDA.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters